BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of over 1000 found
  Current Search:  share: 19042, price: 9001     

HTML
100%
Weekly CEO Buys Highlight: Bruker BioSciences Corp, Dynex Capital Inc, American Dairy Inc, Pioneer Drilling Co
Last weeks top five stocks that were bought by their CEOs were Bruker BioSciences Corp, Dynex Capital Inc, American Dairy Inc, Pioneer Drilling Company, MettlerToledo International Inc.

According to , these are the largest CEO buys during the past week.

Guru Focus:  Mar 22 2010 4:18AM
Matching: share price
Find similar documents
HTML
100%
Agennix AG Raises EUR 9.8 Million (Approximately $13 Million) in Private Placement With Existing Shareholders
Agennix AG (FRANKFURT: AGX) today announced that the Company has raised approximately EUR 9.8 million (approximately $13 million) in a private placement with existing shareholders.

Agennix sold 1,870,523 shares at a price of EUR 5.22 per share....

Genetic Engineering News:  Mar 21 2010 7:50PM
Matching: share price
Find similar documents
HTML
100%
NexMed Bolsters Its Cash Reserve with $1.4 Million Infusion from Successful Mortgage Refinancing on Its New Je
- NexMed, Inc.

(Nasdaq:NEXM), a specialty CRO with a pipeline of products based on the NexACT technology, announced today that it raised $1.4 million in gross proceeds from refinancing the mortgage on its manufacturing facility in New Jersey.

The mortgage...

Pharma Live:  Mar 21 2010 8:53PM
Matching: share price
Find similar documents
HTML
100%
Merge Commences Tenders for AMICAS' Outstanding Shares
Merge Healthcare, a health IT solutions provider, announced that it has commenced a tender offer for all of the outstanding shares of common stock in AMICAS, Inc., a leader in image and information management solutions.

The tender offer is being...

Medicexchange.com:  Mar 20 2010 12:06PM
Matching: share price
Find similar documents
HTML
100%
PDL BioPharma Announces Conversion Rate Adjustments to Convertible Notes
- Company Clarifies Facet Stock Distribution Value - INCLINE VILLAGE, Nev., March 15 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc.

(PDL) (NASDAQ:PDLI) today announced adjustments to the conversion rates for its 2.00% Convertible Senior Notes due February 15,...

Pharma Live:  Mar 20 2010 12:35AM
Matching: share price
Find similar documents
HTML
100%
Merge Healthcare commences tender offer for all outstanding common stock shares of AMICAS
Merge Healthcare (NASDAQ: MRGE) ('Merge'), a health IT solutions provider, announced today that it has commenced a tender offer for all of the outstanding shares of common stock in AMICAS, Inc.

(NASDAQ: AMCS) ('AMICAS'), a leader in image and...

News-Medical.Net:  Mar 20 2010 7:04AM
Matching: share price
Find similar documents
HTML
100%
Marshall Edwards, Inc. Receives Nasdaq Staff Determination
NEW CANAAN, CT (MARKET WIRE) 03/19/10 Marshall Edwards, Inc.

(NASDAQ: MSHL), a specialist oncology company focusing on the clinical development of novel anti-cancer therapeutics, announced today that on March 16, 2010, it received written notification (the ...

Pharmacy Choice:  Mar 20 2010 12:49AM
Matching: share price
Find similar documents
HTML
100%
NYSE Transaction Leaders F, BAC, C, GE and PFE
Ft Lauderdale, Florida 3/19/2010 08:50 PM GMT (TransWorldNews) NYSE transaction leaders in morning trading on Friday, March 19, 2010 are Ford Motor Company, Bank of America, Citigroup, General Electric and Pfizer.

The NYSE transaction leaders are as follows....

TransWorldNews:  Mar 19 2010 10:21PM
Matching: share price
Find similar documents
HTML
100%
Golden Minerals Company Prices US$41.7 Million Offering and Announces Approval of NYSE AMEX Listing
Golden Minerals Company (TSX: AUM) ('Golden Minerals' or 'the Company') today announced the pricing of its public offering of 4,000,000 shares of common stock at a price of US$8.50 per share.

A total of 3,652,234 shares are being...

Genetic Engineering News:  Mar 19 2010 11:19AM
Matching: share price
Find similar documents
HTML
100%
AVEO Pharmaceuticals raises $81 million through initial public of...
Company: AVEO Pharmaceuticals Inc (AVEO) AVEO Pharmaceuticals, Inc., a US-based biopharmaceutical company developing cancer therapeutics, has completed its initial public offering (IPO) of 9 million shares of its common stock at a price of $9 per ...
Zibb:  Mar 19 2010 7:27PM
Matching: share price
Find similar documents
HTML
100%
AVEO Pharmaceuticals raises $81 million through initial public offering
AVEO Pharmaceuticals, Inc., a US-based biopharmaceutical company developing cancer therapeutics, has completed its initial public offering (IPO) of 9 million shares of its common stock at a price of $9 per share raising gross proceeds of $81...
TradingMarkets:  Mar 19 2010 6:38PM
Matching: share price
Find similar documents
HTML
100%
FDA Denies Approval For A. P. Pharma's Nausea Treatment
The Food and Drug Administration issued a complete response letter to A.

Pharma Inc.

(Nasdaq: APPA) denying approval for the company's chemotherapy induced nausea treatment APF530 sending the stock price plummeting 91 cents to $1.15.

The Food and...

About:  Mar 19 2010 5:33PM
Matching: share price
Find similar documents
HTML
100%
Dundee Corporation Acquires Interest in Energizer Resources Inc
In accordance with regulatory requirements, Dundee Corporation (TSX: DC.A) ('Dundee Corp.') announced today that it has acquired an aggregate of 10,000,000 units of Energizer Resources Inc.

('Energizer') at a price of US$0.30 per unit (each a 'Unit')...

Genetic Engineering News:  Mar 19 2010 9:53PM
Matching: share price
Find similar documents
HTML
100%
A.P. Pharma, Netlist: Early Volume Plays
YORK (TheStreet) -- Several stocks trading near $5 were moving on above-average volume during Friday's session.

Pharma (APPA) dropped by $1.08, or 52.7%, to 97 cents after the Food and Drug Administration did not approve its experimental drug APF530 for the...

TheStreet.com:  Mar 19 2010 2:58PM
Matching: share price
Find similar documents
HTML
100%
Bucking Horse Energy Inc. Announces Acquisition of Securities Through Settlement of Outstanding Debt
2:10 PM EST Bucking Horse Energy Inc.

(the 'Company' and 'Bucking Horse') (TSX: BUC) announces that it has acquired through its wholly-owned subsidiary Gemini Energy Corp.

('Gemini') 600,000 common shares of XXL Energy Corp.

('XXL').

The...

Genetic Engineering News:  Mar 19 2010 2:49AM
Matching: share price
Find similar documents
HTML
100%
Pinetree Capital Ltd. Acquires Securities of Kirrin Resources Inc
common shares ('Common Shares') and 1,500,000 common share purchase warrants (the 'Warrants') of Kirrin Resources Inc.

('Kirrin').

Each Warrant entitles the holder thereof to acquire one additional common share at a price of $0...

Genetic Engineering News:  Mar 19 2010 9:52PM
Matching: share price
Find similar documents
HTML
100%
MBMI Closes Private Placement
3:30 PM EST MBMI RESOURCES INC.

('MBMI' or the 'Company') (TSX VENTURE: MBR) reports that further to its January 29, 2010 news release, it has closed the first two tranches of its non-brokered Private Placement financing.

The Company has received gross...

Genetic Engineering News:  Mar 19 2010 2:49AM
Matching: share price
Find similar documents
HTML
100%
Stockguru.com: PROLOR Biotech Inc. is in the StockGuru Spotlight for March 19, 2010
On Thursday, the company put out news announcing that the company has raised $24.4 million in a private placement of 10,382,975 shares of its common stock, par value $0.00001 per share, to accredited investors at a price of $2.35 per share,...
TradingMarkets:  Mar 19 2010 10:46AM
Matching: share price
Find similar documents
HTML
100%
Derma Sciences, Inc. (DSCI) Announces Full Exercise of Over-Allotment Option and Closing of Public Equity Offe
/PRNewswire via COMTEX/ -- /quotes/comstock/15*!dsci/quotes/nls/dsci (DSCI 5.69, -0.09, -1.56%) , a specialty medical device/pharmaceutical company focused on advanced wound care, today announced that the underwriter of its recent public offering has exercised...
BioSpace:  Mar 19 2010 9:35PM
Matching: share price
Find similar documents
HTML
100%
Commercial Vehicle Group expects $22M in offering
Heavy truck equipment supplier Commercial Vehicle Group Inc.

said Friday it expects its public offering of 3.8 million shares at $6.25 a share will result in proceeds of at least $22 million, after expenses.

The company plans to use the proceeds...

Research & Development:  Mar 19 2010 4:51PM
Matching: share price
Find similar documents
HTML
100%
Marshall Edwards, Inc. (NVGN) Receives Nasdaq Staff Determination
- Highlighted Links (NASDAQ: MSHL), a specialist oncology company focusing on the clinical development of novel anti-cancer therapeutics, announced today that on March 16, 2010, it received written notification (the 'Staff Determination') from The Nasdaq Stock...
BioSpace:  Mar 19 2010 9:35PM
Matching: share price
Find similar documents
HTML
100%
Abraham, Fruchter & Twersky, LLP Announces Filing of a Class Action Lawsuit Against AMAG Pharmaceuticals, Inc.
The complaint charges the Company and certain of its officers with violations of the Securities Act.

AMAG is a biopharmaceutical company engaged in the development and commercialization of therapeutic iron compounds to treat anemia worldwide.

According to...

TradingMarkets:  Mar 19 2010 5:22PM
Matching: share price
Find similar documents
HTML
100%
Theravance Announces Pricing of Public Offering of Common Stock
Theravance, Inc.

(NASDAQ: THRX), a biopharmaceutical company with a pipeline of internally discovered product candidates, today announced that it has priced its public offering of 7,500,000 shares of its common stock at a price to the public...

NewsBlaze:  Mar 19 2010 5:21PM
Matching: share price
Find similar documents
HTML
100%
Marshall Edwards, Inc. Receives Nasdaq Staff Determination
Marshall Edwards, Inc.

(NASDAQ: MSHL), a specialist oncology company focusing on the clinical development of novel anti-cancer therapeutics, announced today that on March 16, 2010, it received written notification (the 'Staff Determination') from The Nasdaq...

NewsBlaze:  Mar 19 2010 5:21PM
Matching: share price
Find similar documents
HTML
100%
Abraham, Fruchter & Twersky, LLP Announces Filing of a Class Action Lawsuit Against AMAG Pharmaceuticals, Inc
The complaint charges the Company and certain of its officers with violations of the Securities Act.

AMAG is a biopharmaceutical company engaged in the development and commercialization of therapeutic iron compounds to treat anemia worldwide.

According to...

Yahoo! Finance:  Mar 19 2010 4:24PM
Matching: share price
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.